The Law Offices Of Vincent Wong Announce An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of NovaMed, Inc. In Connection With The Sale Of The Company To Surgery Center Holdings, Inc. - NOVA
The Law Offices of Vincent Wong are investigating the Board of Directors of NovaMed, Inc. (Nasdaq: NOVA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Surgery Center Holdings, Inc. which is an affiliate of H.I.G. Capital, LLC. Under the terms of the proposed deal, NovaMed shareholders will receive $13.25 in cash per share. The total transaction is value of approximately $214 million, including the assumption of debt.
The investigation concerns whether the NovaMed Board of Directors breached their fiduciary duties to NovaMed stockholders by failing to adequately shop the Company before entering into this transaction and whether Surgery Center Holdings is underpaying for NovaMed shares. One analyst reported by Thomson/First Call set a price target of $18 per share for NovaMed stock and the company's shares traded at $13.25 as recently as January 18, 2011.
If you own common stock in NovaMed and wish to obtain additional information, please contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.584.2740, or visit http://www.wongesq.com/novamed-nova.html.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
